Xponance, Inc. Quidel Ortho Corp Transaction History

Xponance, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$41.76 - $74.73 $4,927 - $8,818	-118 Reduced 1.94%	5,974 $286,000
Q4 2023 Jan 31, 2024	BUY	$58.16 - $75.44 $1,919 - $2,489	33 Added 0.54%	6,092 $448,000
Q3 2023 Oct 23, 2023	SELL	$70.9 - $88.63 $55,727 - $69,663	-786 Reduced 11.48%	6,059 $442,000
Q2 2023 Jul 13, 2023	SELL	$81.09 - $94.16 $6,325 - $7,344	-78 Reduced 1.13%	6,845 $567,000
Q1 2023 Apr 17, 2023	BUY	$82.98 - $91.46 $5,061 - $5,579	61 Added 0.89%	6,923 $616,000
Q4 2022 Jan 23, 2023	BUY	$66.93 - $97.5 $36,142 - $52,650	540 Added 8.54%	6,862 $0
Q3 2022 Oct 24, 2022	BUY	$69.86 - $107.63 $24,031 - $37,024	344 Added 5.75%	6,322 $452,000
Q2 2022 Aug 02, 2022	BUY	$89.06 - $117.64 $532,400 - $703,251	5,978 New	5,978 $581,000

293

67.9M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.51B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.